General Information of Drug (ID: DM0JUAL)

Drug Name
ChelASE Drug Info
Synonyms VitrenASE; VIT-100
Indication
Disease Entry ICD 11 Status REF
Retina disorder 9B70-9B7Z Discontinued in Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM0JUAL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ATX-101 DM64WYC Obesity 5B81 Phase 3 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Proliferating cell nuclear antigen (PCNA) TTLG1PD PCNA_HUMAN Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017704)
2 Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol. 2007 Sep;125(9):1161-7.
3 Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells. PLoS One. 2013 Jul 31;8(7):e70430.